Advertisement
News
Advertisement

MedCap Advisors Names Edward Ahn Managing Director and Chief Science Officer

Thu, 09/06/2012 - 9:00am
The Associated Press

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sep 6, 2012--MedCap Advisors, the mergers & acquisition and strategic consulting firm specializing in medical technology, today announced it has appointed Edward Ahn, Ph. D., as Managing Director and Chief Science Officer. Dr. Ahn is a leading expert in the development and commercialization of biomaterials nanotechnology, with over 10 years of industrial and academic experience.

"We are extremely fortunate to have a professional of Edward's caliber join our firm," said Mr. Christopher Velis, CEO of MedCap Advisors. "His expertise is perfectly in tune with our mission to improve health and medical technology, as we stay focused on the intersection at which physicians and patients meet. Ed will be a significant contributor to our team and to our clients." Dr. Ahn most recently served as Vice President of Biologics Product Development for Pioneer® Surgical Technology, Inc. and its newly formed biologics division. He successfully developed and launched novel synthetic bone grafts, allograft-based tissue products and structural calcium phosphate nanotechnology in interbody spinal fusion.

In 2001, Dr. Ahn won the Grand Prize in the MIT $50k Business Plan Competition and subsequently used his thesis to found Angstrom Medica, a company focused on commercializing nanotechnology in orthopedics. Here he achieved the first nanomedical device approved by the FDA in 2005; the company was subsequently acquired by Pioneer® Surgical Technology, Inc.

Dr. Ahn earned his B.S. in Chemical Engineering from Stanford University and M.S. in Chemical Engineering Practice and Ph.D. in Chemical Engineering from MIT. Presently he is a senior lecturer at Harvard University's School of Engineering and Applied Science, and is the Vice-Chairman of the MIT Enterprise Forum of Cambridge. He is also a member of the Scientific Advisory Board of the Center of Innovation for Nanobiotechnology (COIN) and a principal of First Founders, Ltd., a not-for-profit corporation dedicated to building young business ventures emerging from academic and other institutional research.

This announcement also follows on the news of MedCap’s move to larger space in Harvard Square in Cambridge.

About MedCap Advisors, LLC MedCap Advisors, LLC provides sophisticated strategic business and M&A consulting services exclusively to the medical technology and healthcare sectors. With more than 20 years of expertise in emerging medical devices, biotechnologies, and biologics, the firm's advisers are authorities in the full spectrum of strategic, scientific, and financial strategies that drive the medical marketplace. For more information, please visit www.medcapadvisors.com.

CONTACT: Ebben Zall Group Michelle Juralewicz, 781-449-3244 michelle@ebbenzallgroup.com KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY MEDICAL DEVICES PROFESSIONAL SERVICES BANKING FINANCE GENERAL HEALTH SOURCE: MedCap Advisors, LLC Copyright Business Wire 2012 PUB: 09/06/2012 09:00 AM/DISC: 09/06/2012 09:00 AM http://www.businesswire.com/news/home/20120906005255/

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading